Entera Bio Ltd (ENTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Entera Bio Ltd-Aktie (ENTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.042	0.082	0.042	0.057
Cost Of Revenue	100.00% -	0.042	0.082	0.042	0.048
Gross Profit	-	-	-	-	0.009
Operating Expenses	4.10% 2.668	2.563	2.337	3.021	2.174
Benefits Costs and Expenses	-	-	2.426	3.063	-
Costs And Expenses	2.42% 2.668	2.605	2.426	3.063	2.222
Operating Income/Loss	4.10% -2.668	-2.563	-2.337	-3.021	-2.165
Nonoperating Income/Loss	400.00% 0.012	-0.004	-0.007	-	0.02
Income/Loss From Continuing Operations Before Tax	6,424% -2.656	0.042	-2.344	-3.021	0.057
Income/Loss From Continuing Operations After Tax	3.47% -2.656	-2.567	-2.358	-3.021	-2.145
Net Income/Loss	3.47% -2.656	-2.567	-2.358	-3.021	-2.145
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7.97% 46.84	43.38	0.4867	37.64	37.09
Diluted Average Shares	7.97% 46.84	43.38	0.4867	37.64	37.09
Basic Earnings Per Share	0.00% 0.06	0.06	0.06	0.08	0.06
Diluted Earnings Per Share	0.00% 0.06	0.06	0.06	0.08	0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$24.78

0.98%

INCY

$84.84

1.00%

SMMT

$24.80

8.06%

BNTX

$103.01

1.70%

INSM

$134.53

1.79%

ONC

$300.14

2.84%